Invention Grant
- Patent Title: Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of glaucoma
-
Application No.: US16626630Application Date: 2018-06-27
-
Publication No.: US11746149B2Publication Date: 2023-09-05
- Inventor: Bongcheol Kim , Dong Sik Kim , Soon-gu Kwon
- Applicant: Neuracle Science Co., Ltd.
- Applicant Address: KR Seoul
- Assignee: Neuracle Science Co., Ltd.
- Current Assignee: Neuracle Science Co., Ltd.
- Current Assignee Address: KR Seoul
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- International Application: PCT/IB2018/054782 2018.06.27
- International Announcement: WO2019/003162A 2019.01.03
- Date entered country: 2019-12-26
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/24
Abstract:
The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat a glaucoma in a subject in need thereof.
Public/Granted literature
- US20200157202A1 USE OF ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES FOR THE TREATMENT OF GLAUCOMA Public/Granted day:2020-05-21
Information query
